A high frequency and a significantly inferior survival of RUNX1 co‐mutations in patients with AML or MDS carrying ASXL1mt was observed in previous studies, both in the elderly cohort39, 40 and the younger cohort.23 The gene discussed is RUNX1; the disease is acute myeloid leukemia.